These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 34868073)
41. Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection. Kim YJ; Ko EJ; Kim MC; Lee YN; Kim KH; Jung YJ; Kang SM Biochem Biophys Res Commun; 2017 Nov; 493(1):393-398. PubMed ID: 28887040 [TBL] [Abstract][Full Text] [Related]
42. In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen. Wohlbold TJ; Krammer F Viruses; 2014 Jun; 6(6):2465-94. PubMed ID: 24960271 [TBL] [Abstract][Full Text] [Related]
43. Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine. Rockman S; Brown LE; Barr IG; Gilbertson B; Lowther S; Kachurin A; Kachurina O; Klippel J; Bodle J; Pearse M; Middleton D J Virol; 2013 Mar; 87(6):3053-61. PubMed ID: 23283953 [TBL] [Abstract][Full Text] [Related]
44. Universal Influenza Vaccine Approaches Using Full-Length or Head-Only Hemagglutinin Proteins. Ross TM J Infect Dis; 2019 Apr; 219(Suppl_1):S57-S61. PubMed ID: 30715379 [TBL] [Abstract][Full Text] [Related]
45. The Quest for a Truly Universal Influenza Vaccine. Jang YH; Seong BL Front Cell Infect Microbiol; 2019; 9():344. PubMed ID: 31649895 [TBL] [Abstract][Full Text] [Related]
46. Biological and protective properties of immune sera directed to the influenza virus neuraminidase. Halbherr SJ; Ludersdorfer TH; Ricklin M; Locher S; Berger Rentsch M; Summerfield A; Zimmer G J Virol; 2015 Feb; 89(3):1550-63. PubMed ID: 25392225 [TBL] [Abstract][Full Text] [Related]
47. Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015. Hampson A; Barr I; Cox N; Donis RO; Siddhivinayak H; Jernigan D; Katz J; McCauley J; Motta F; Odagiri T; Tam JS; Waddell A; Webby R; Ziegler T; Zhang W Vaccine; 2017 Feb; 35(8):1104-1109. PubMed ID: 28131392 [TBL] [Abstract][Full Text] [Related]
48. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R mBio; 2017 Sep; 8(5):. PubMed ID: 28928215 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model. Memoli MJ; Shaw PA; Han A; Czajkowski L; Reed S; Athota R; Bristol T; Fargis S; Risos K; Powers JH; Davey RT; Taubenberger JK mBio; 2016 Apr; 7(2):e00417-16. PubMed ID: 27094330 [TBL] [Abstract][Full Text] [Related]
50. Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine. Wang Z; Li Z; Su X; Qiao Y; Fan W; Li H; Shi B; Qin T; Chen S; Peng D; Liu X Vaccine; 2019 Mar; 37(13):1736-1742. PubMed ID: 30797637 [TBL] [Abstract][Full Text] [Related]
57. Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice. Wang W; Li R; Deng Y; Lu N; Chen H; Meng X; Wang W; Wang X; Yan K; Qi X; Zhang X; Xin W; Lu Z; Li X; Bian T; Gao Y; Tan W; Ruan L Clin Vaccine Immunol; 2015 Jun; 22(6):618-30. PubMed ID: 25834017 [TBL] [Abstract][Full Text] [Related]
58. Virus-like particles as universal influenza vaccines. Kang SM; Kim MC; Compans RW Expert Rev Vaccines; 2012 Aug; 11(8):995-1007. PubMed ID: 23002980 [TBL] [Abstract][Full Text] [Related]
59. Squalene-containing licensed adjuvants enhance strain-specific antibody responses against the influenza hemagglutinin and induce subtype-specific antibodies against the neuraminidase. Schmidt R; Holznagel E; Neumann B; Alex N; Sawatsky B; Enkirch T; Pfeffermann K; Kruip C; von Messling V; Wagner R Vaccine; 2016 Oct; 34(44):5329-5335. PubMed ID: 27616472 [TBL] [Abstract][Full Text] [Related]